Life Settlement Bonds and Securities
The Difference Between Life Settlement Bonds and Reg XXX / AXXX Securitizations
Life Settlement Bonds and Securities — Structure, Market History, Named Participants, the LE Underwriter Framework, and the Defining Episodes of the Asset Class
Life settlement securitizations are insurance-linked structured finance transactions in which pools of life insurance policies acquired in the secondary market are financed through the issuance of long-dated securities backed by the actuarially projected death benefits of insured individuals. These instruments occupy a distinct segment of the capital markets at the intersection of life insurance, alternative credit, longevity risk transfer, and structured finance, and are fundamentally driven by mortality expectations, premium funding requirements, policy servicing performance, and legal enforceability rather than by traditional financial asset performance. The U.S. secondary market for life insurance policies reached $12.2 billion in face value of policies traded in 2007 — the pre-crisis peak — before contracting sharply to $1.3 billion in 2011 under the combined pressure of the financial crisis, LE provider methodology revisions, and regulatory scrutiny, and has since recovered toward $4.6 billion in 2020 and is projected to reach $45 billion annually by 2027 as major alternative asset managers including Apollo and Blackstone have entered the space.
https://content.naic.org/sites/default/files/inline-files/MDL-697.pdf
https://content.naic.org/sites/default/files/consumer_life_settlements.pdf
Corvid Partners is a global leader in valuing and analyzing complex structured finance and insurance securitization transactions, including life settlement bond transactions, longevity-linked securities, and other insurance-risk-transfer structures. Members of Corvid have traded, structured, restructured, and valued these securities across multiple market cycles, including the early expansion of the life settlement market in the 2000s, the dislocations surrounding the global financial crisis, the failures of certain retail-distributed bond programs, and the current environment characterized by litigation, restructuring, and valuation-driven analysis of legacy portfolios. The principals whose work defines Corvid's approach to this market inherited a meaningful portfolio of life settlement securities from Lehman Brothers as part of Barclays' acquisition of Lehman's U.S. broker-dealer operations in September 2008. Those securities — purchased in the secondary market from a firm that had been among the most active capital markets participants in the life settlement space before its bankruptcy — traded into the single digits on a dollar price basis in the acute phase of the financial crisis as investors fled illiquid assets and LE assumption revisions created fundamental uncertainty about portfolio values. The subsequent recovery in those positions, as mortality experience on the underlying portfolios stabilized and the technical selling pressure resolved, generated returns that demonstrated precisely the analytical point that defines the asset class: that when markets price these securities as worthless based on liquidity panic rather than actuarial impairment, the correct response for an investor who can hold and accurately model the underlying cash flows is to buy rather than to sell.
The Difference Between Life Settlement Bonds and Reg XXX/AXXX Securitizations
The terminology associated with these transactions reflects their origin in the secondary market for life insurance policies. A life settlement refers to the sale of an in-force life insurance policy by the policyholder to a third-party investor for an amount greater than the surrender value but less than the death benefit. The investor assumes responsibility for future premium payments and receives the death benefit upon the insured's death. The regulatory framework governing these transactions is primarily state-based, coordinated through model laws adopted by the National Association of Insurance Commissioners.
https://content.naic.org/sites/default/files/inline-files/MDL-697.pdf
https://content.naic.org/sites/default/files/consumer_life_settlements.pdf
When life settlement portfolios are financed through capital markets transactions, the resulting securities are commonly referred to as life settlement bonds, life settlement securitizations, longevity bonds, or mortality-linked securities. These instruments are sometimes described colloquially as death bonds, although the term also appears in discussions of Regulation XXX/AXXX reserve financings and other mortality-linked instruments, and the structures are economically distinct.
https://www.investopedia.com/terms/l/life-settlement.asp
https://www.investopedia.com/terms/d/deathbond.asp
In comparison to Regulation XXX/AXXX securitizations, life settlement securitizations differ in several fundamental respects. Regulation XXX/AXXX transactions finance statutory reserve requirements on newly issued policies and are driven by regulatory capital inefficiencies, while life settlement securitizations finance portfolios of existing policies purchased from original policyholders. Regulation XXX/AXXX cash flows arise from premiums, reserves, and reinsurance recoverables, whereas life settlement cash flows arise primarily from death benefits. Both structures rely on actuarial projections, long-dated assumptions, and bankruptcy-remote SPVs, but the legal, regulatory, and economic risks differ materially. Life settlement bonds also differ from catastrophe bonds and other insurance-linked securities: catastrophe bonds transfer short-duration event risk triggered by specific natural or man-made disasters, while life settlement bonds transfer long-duration longevity risk accumulated across portfolios of individual human lifespans. As a result, life settlement securitizations tend to have longer maturities, greater model dependence, and lower liquidity than either ILS or XXX/AXXX structures.
The Origin and Legal Framework of the Life Settlement Market
The development of life settlement securitizations is best understood against the backdrop of the emergence of the life settlement industry in the 1990s and early 2000s. The market's origins trace to the AIDS epidemic of the 1980s, when viatical settlements — the sale of life insurance policies by terminally ill individuals to third-party investors at a discount to the death benefit — first emerged as a financial product. As the AIDS crisis evolved and medical treatments improved, extending life expectancies far beyond original viatical pricing assumptions, the market evolved from viatical settlements focused on the terminally ill toward life settlements focused on elderly but not terminally ill policyholders who no longer needed or could afford their coverage. Improvements in life expectancy modeling, increased institutional participation, and legal clarification regarding the assignability of life insurance policies led to the growth of a secondary market in which policies could be bought and sold as financial assets.
https://scholarship.law.upenn.edu/faculty_scholarship/143
https://www.naic.org/documents/consumer_alert_life_settlements.htm
Court decisions confirming the legality of policy transfers, together with state legislation regulating settlement providers, created the legal foundation for institutional investment in life insurance policies. The NAIC took a crucial step in 2001 by releasing the Viatical Settlements Model Act defining guidelines for avoiding fraud and ensuring sound business practices. Around this time, many of the life settlement providers prominent today began purchasing policies using institutional capital — transforming the settlement concept into a regulated wealth management tool for high-net-worth policyowners. The market grew at an annual rate of approximately 43.6 percent between 2002 and 2007 according to The Deal's Life Settlement Report, reaching the $12.2 billion peak in 2007.
https://elsa-sls.org/wp-content/uploads/2023/09/ELSA-Fact-Sheet-Q3.pdf
The legal concept of insurable interest plays a central role in the validity of life settlement transactions. U.S. law generally requires that a life insurance policy be issued to a party with an insurable interest in the insured, but once validly issued, the policy may often be transferred to a third party. Litigation involving stranger-originated life insurance — policies issued from inception with the intent of immediately selling them to investors who had no insurable interest in the insured at the time of issuance — has been a major source of legal risk in settlement portfolios, with courts in several jurisdictions voiding policies deemed to lack a valid insurable interest at inception.
https://law.justia.com/cases/delaware/supreme-court/2011/174-2011.html
The Structure of a Life Settlement Securitization
As the volume of policies held by institutional investors increased, market participants began to explore securitization as a means of financing premium obligations and monetizing expected death benefits. A typical life settlement securitization involves a sponsor or investment manager that acquires a portfolio of life insurance policies through licensed settlement providers. The policies are transferred to a bankruptcy-remote special purpose vehicle, which issues notes to investors in a private placement, typically under Rule 144A and Regulation S of the U.S. Securities Act.
https://www.sec.gov/divisions/corpfin/guidance/securitiesactrules-interps.htm
The proceeds from the issuance of notes are used to fund the purchase of policies and to establish premium reserve accounts that cover expected future premium payments. Cash flows supporting the securities arise primarily from death benefits, with interim funding provided by premium reserves and investment income. The transaction waterfall governs the allocation of cash flows among servicing fees, premiums, expenses, interest, principal, and residual equity distributions.
The structural design of these transactions reflects multiple layers of risk that differ materially from those present in Regulation XXX/AXXX securitizations. Mortality timing determines when cash flows are realized. Premium funding risk determines whether policies remain in force — if premium reserves are exhausted before sufficient mortality occurs, policies lapse and the death benefit is lost entirely, destroying value for all noteholders. Servicing risk determines whether policies are properly maintained and premium payments properly executed. Legal enforceability of policy ownership, insurable interest requirements, and compliance with state settlement laws are also critical to isolating cash flows.
https://www.casact.org/sites/default/files/database/forum_2009_01forum_09wforum_01.pdf
From a regulatory perspective, life settlement securitizations are governed by a combination of state insurance law, securities law, and structured finance practice. State life settlement statutes regulate licensing, disclosure, and consumer protections, while securities offerings are typically exempt from registration but subject to anti-fraud provisions and disclosure requirements.
https://content.naic.org/sites/default/files/inline-files/MDL-697.pdf
https://www.sec.gov/about/offices/ocie/riskalert-lifesettlements.pdf
The Life Expectancy Underwriter Framework — AVS, 21st Services, Fasano Associates, and the Big Five
Valuation of life settlement securitizations requires integrating actuarial modeling with structured finance analysis. The central analytical input — more important than the structural waterfall, the premium reserve sizing, or the discount rate — is the life expectancy estimate produced by independent medical underwriters for each insured individual in the portfolio. These estimates are prepared by specialized firms that employ physicians and actuaries to review the complete medical records of each insured and produce a mortality rating expressed as a multiplier against a standard mortality table. A rating above 100 percent indicates impaired health and higher-than-standard expected mortality; a lower LE estimate increases the present value of the expected death benefit and therefore the purchase price of the policy.
https://www.tandfonline.com/doi/full/10.1080/10920277.2019.1585881
The five major life expectancy providers — known in the market as the Big Five — are AVS Underwriting, Fasano Associates, ISC Services, 21st Services, and EMSI. In October 2010, four of the Big Five — AVS, 21st Services, EMSI, and ISC Services — formed the Life Expectancy Providers consortium to establish common standards for reporting actual-to-expected mortality performance, in a debate that reflected deep disagreement about how to measure LE provider accuracy. Fasano Associates, whose president Mike Fasano sat on the Life Insurance Settlement Association board, took a different methodological position. The four-firm LEPr group preferred to include restated LE estimates in evaluating forecast accuracy; LISA preferred to use original estimates as provided to clients. This debate was not academic — it determined whether providers were accountable to their original mortality forecasts or could restate them retroactively as longevity experience came in worse than predicted.
https://www.tandfonline.com/doi/full/10.1080/10920277.2019.1585881
https://fasanoassociates.com/enhanced-services/
The systematic optimism in early LE estimates — particularly for policies underwritten before 2006 — was the primary cause of performance disappointments in pre-crisis life settlement portfolios. Academic analysis of the Fasano dataset found that LE estimates compiled before 2006 were on average approximately 10 percent too short — meaning the insured lived about 10 percent longer than projected, delaying death benefit realization and increasing the cumulative premium burden. AVS Underwriting updated its underwriting methodology in 2008 and again in 2012, and 21st Services similarly revised its methodology in 2008 and 2014. These revisions — which extended LE estimates for older cohorts, sometimes dramatically — produced sudden reductions in portfolio net asset value for funds that had marked positions using the pre-revision estimates. A fund that had underwritten a portfolio to an average LE of 84 months and then received revised LEs of 100 months suddenly held assets worth materially less than their carrying value, with premium commitments now extending 16 months longer than originally modeled. For leveraged funds, these LE revisions could trigger margin calls, forced selling, and cascading losses.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6583892/
https://www.gisfunds.com/mortality-estimates-life-settlements/
Analysts must project mortality using life expectancy estimates, medical underwriting data, and stochastic mortality models, then forecast premium requirements, servicing costs, and transaction expenses. These projected cash flows are applied through the transaction waterfall and discounted using assumptions that incorporate longevity risk, liquidity risk, legal risk, and structural complexity. Unlike traditional asset-backed securities, life settlement bonds often exhibit negative carry in early years because premium payments exceed death benefits until sufficient mortality occurs. As a result, the timing of deaths has a large impact on returns, and small changes in life expectancy assumptions can materially alter valuation. Academic research has emphasized the sensitivity of settlement investments to longevity modeling and correlation assumptions.
https://www.nber.org/papers/w11352
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1106964
Rating agency analysis of life settlement securitizations focuses on mortality stress scenarios, premium funding adequacy, portfolio diversification, legal enforceability, servicer performance, and structural protections. Because cash flows depend on human longevity rather than financial assets, rating methodologies differ significantly from those applied to traditional ABS.
Pre-Crisis Market Expansion, the Financial Crisis, and the Barclays/Lehman Position
The life settlement securitization market expanded rapidly in the early 2000s as hedge funds, private equity firms, and dedicated longevity funds accumulated large policy portfolios. Between 2003 and 2007, life settlement funds generated the third highest total return of all analyzed asset classes according to academic research — with only hedge funds and government bonds providing higher total returns over that period — and with very low correlation to traditional equity and fixed-income markets. Transactions were typically privately placed and structured with multiple tranches of notes and equity, attracting institutional investors seeking uncorrelated returns. The annual growth rate of 43.6 percent from 2002 to 2007 documented by The Deal reflects both genuine market development and the distortion of STOLI-originated policies entering the secondary market at inflated volumes.
https://www.vwrm.rw.fau.de/files/2016/05/Life_settlement_funds_2011-02-11_WP.pdf
https://elsa-sls.org/wp-content/uploads/2023/09/ELSA-Fact-Sheet-Q3.pdf
The 2008 financial crisis produced severe dislocations in the life settlement securitization market. Secondary trading in life settlement bonds collapsed as institutional investors reduced risk across all illiquid asset classes simultaneously. Securities that had been valued on the basis of actuarially projected cash flows were suddenly marked at prices reflecting liquidity panic — in many cases trading into the single digits on a dollar price basis — as no bid existed in the secondary market and holders facing margin calls or redemption requests had no mechanism for price discovery other than distressed selling to the handful of buyers willing to analyze the underlying mortality and premium economics. The dislocation was compounded by the simultaneous LE provider methodology revisions of 2008, which extended life expectancy estimates and thereby reduced the present value of portfolio cash flows at exactly the moment when liquidity had vanished. For any investor with the analytical capacity to distinguish technical selling from fundamental impairment and the capital to hold positions through the dislocation, however, the crisis created one of the most unusual return opportunities in the asset class's history: securities backed by death benefits payable on policies owned by elderly individuals whose mortality experience was unaffected by the financial crisis — life settlements are by design uncorrelated with financial market conditions, since the insured individuals were dying at approximately their expected rates regardless of what was happening in credit markets — trading at prices that implied catastrophic loss of premium-funded portfolios with adequate reserves.
https://airassetmanagement.com/insights/life-settlement-market-ready-to-flex-its-newfound-maturity
The principals whose work defines Corvid's approach to this market found themselves holding a meaningful portfolio of life settlement securities inherited from Lehman Brothers through Barclays' acquisition of Lehman's U.S. broker-dealer operations in September 2008. These positions — trading at single-digit dollar prices in the acute crisis phase — were the kind of assets that required exactly the analytical discipline the asset class demands: independently modeling the underlying LE assumptions, verifying the premium reserve adequacy, assessing the STOLI exposure within the portfolio, and making a judgment about whether the prices reflected genuine impairment of the underlying mortality economics or purely technical selling by distressed counterparties. The conclusion — that the fundamental cash flows were more intact than the prices implied — and the patience to hold through the recovery produced returns that were not achievable through any other analytical approach to this market.
GWG Holdings — The Defining Post-Crisis Failure
The global financial crisis slowed new issuance, but activity continued in the following decade, including large institutional transactions as well as retail-distributed bonds backed by settlement portfolios. The most consequential and damaging retail-distributed failure was GWG Holdings and its L Bond program.
https://www.sec.gov/litigation/admin/2022/33-11031.pdf
https://www.justice.gov/usao-sdtx/pr/gwg-holdings-inc-files-bankruptcy
GWG Holdings, a Dallas-based financial services company, began issuing L Bonds in 2012 — unrated, speculative, illiquid securities sold to retail investors in minimum denominations of $25,000 through a network of approximately 40 broker-dealers including Emerson Equity, Aegis Capital, and Centaurus Financial. The L Bonds, marketed as high-yield instruments backed by life insurance policies purchased on the secondary market, accumulated $1.626 billion in outstanding principal by the time GWG filed for Chapter 11 bankruptcy in the Southern District of Texas on April 20, 2022, listing approximately $2 billion in total liabilities. The L Bond investor base — approximately 27,000 bondholders, heavily weighted toward retirees and conservative savers seeking income — was the direct consequence of a distribution model that paired institutional-style insurance-linked securities with a retail investor base entirely unsuited to their illiquidity, complexity, and risk profile.
https://klaymantoskes.com/gwg-holdings-l-bonds-lawsuit/
The failure of GWG had two distinct causes that operated simultaneously. The first was the inherent structural challenge of the L Bond model: a life settlement portfolio generates negative carry in early years because premiums must be paid before sufficient mortality occurs to generate death benefit income, and the GWG structure was dependent on continuous new L Bond sales to fund both premium payments and redemptions — a dependency that the Official Committee of Bondholders characterized as a classic Ponzi scheme dynamic. The second was outright alleged fraud. Starting in 2018, GWG shifted its business model away from life settlements and toward investing in The Beneficient Company Group, an entity controlled by Brad Heppner, who had also become GWG's board chairman. Between 2019 and 2021, Heppner allegedly caused approximately $300 million in transfers between GWG and Beneficient, diverting over $150 million to entities he controlled — including fabricating a $141 million debt that Beneficient purportedly owed through a shell entity called Highland Consolidated Limited Partnership. GWG defaulted on $13.6 million in scheduled interest and principal payments on January 15, 2022, and filed for bankruptcy three months later. Heppner was arrested November 4, 2025 in Dallas on federal charges including securities fraud, wire fraud, conspiracy, false statements to auditors, and falsification of records, in United States v. Heppner, Case 25 Cr. 503, assigned to Judge Jed S. Rakoff in the Southern District of New York, with trial set for April 6, 2026.
https://www.iorio.law/blog/gwg-l-bond-settlement-beneficient-heppner/
The recovery for L Bond investors has been devastating: total settlements approved through June 2025 reached approximately $91.3 million — representing approximately 5.6 percent of the $1.626 billion outstanding — of which approximately $59.8 million is estimated to be available for distribution to bondholders, producing an expected payout of approximately $31.48 per $1,000 of bonds or roughly three cents on the dollar. The life settlement portfolio itself — originally valued in GWG's financial statements at approximately $794.7 million — was sold in October 2023 for $10 million, yielding effectively nothing for bondholders after expenses. Bankruptcy Judge Marvin Isgur described the expected outcome for bondholders as no material recovery.
https://klaymantoskes.com/gwg-holdings-l-bonds-lawsuit/
These events led to increased regulatory scrutiny by the SEC, state regulators, and insurance authorities, as well as greater emphasis on disclosure, valuation transparency, and servicing oversight across the broader life settlement market.
The Current Market and the COVID Longevity Effect
Today, the market for life settlement securitizations is relatively small and highly specialized by the standards of other structured credit markets, but it is growing. The secondary market reached $4.6 billion in face value of policies purchased in 2020, with 3,241 policies traded. ISC Services projects the market will reach $45 billion annually by 2027, driven by demographic aging, low policy penetration rates relative to the total universe of lapsable policies, and institutional interest from major alternative asset managers. Apollo and Blackstone have publicly cited life settlements as a compelling longevity and alternative yield opportunity.
https://windsorsettlements.com/why-investors-eyeing-life-settlements/
https://en.wikipedia.org/wiki/Life_settlement
One of the most important and analytically underappreciated developments in the recent history of this market is the COVID-19 pandemic's effect on the insured population. Because life settlement portfolios are concentrated in older individuals — typically over 70, often with pre-existing cardiovascular, pulmonary, or oncological conditions that make them likely life settlement candidates — they were disproportionately represented in the COVID excess mortality wave of 2020 and 2021. The pandemic accelerated the mortality of the precise demographic that life settlement investors hold, producing a wave of death benefit realizations earlier than models had projected. This phenomenon — mortality acceleration rather than extension — temporarily improved the realized performance of many life settlement portfolios relative to their pre-COVID actuarial projections, demonstrating in stark terms the uncorrelated nature of the asset class: when the COVID pandemic was devastating equity markets, travel stocks, and hospitality REITs, life settlement portfolios were realizing death benefits ahead of schedule. Investors who had held these positions through the 2008 dislocation, the LE revision cycles of 2008 to 2014, and the GWG-driven reputational damage of 2019 to 2022 were rewarded with an actuarial tailwind produced by the most severe pandemic in a century.
Most activity today involves legacy portfolios, restructurings, secondary trading, and valuation disputes rather than large volumes of new securitization issuance. Pricing is typically model-driven, transactions trade over-the-counter, and investors require expertise in actuarial science, insurance law, and structured finance to evaluate risk. The tertiary trading market — in which whole portfolios of life settlement policies are bought and sold between institutional investors — has developed substantially since the crisis and now exceeds secondary market volume, reflecting improved standardization and price discovery at the portfolio level.
https://airassetmanagement.com/insights/life-settlement-market-ready-to-flex-its-newfound-maturity
Conclusion
The life settlement securitization market's history is defined by three recurring tensions: between the genuine uncorrelated return potential of mortality-linked assets and the complexity of accurately modeling when that mortality will occur; between institutional-quality analytical frameworks and the retail distribution channels that exposed vulnerable investors to risks they could not evaluate; and between the fundamental soundness of the asset class — death benefits are paid by regulated insurance carriers on legally owned policies, and the insured will eventually die — and the technical and model-driven dislocations that in 2008 drove prices into the single digits on securities whose underlying mortality economics remained intact. The LE provider framework — the Big Five underwriters whose AVS, 21st Services, Fasano, ISC, and EMSI estimates determine policy values — has improved substantially since the systematic optimism of pre-2006 underwriting, with modern actual-to-expected ratios consistently within 98 to 102 percent for the leading providers. The GWG Holdings collapse, with $1.626 billion in L Bonds ultimately returning approximately three cents on the dollar, is the canonical example of what happens when a fundamentally sound asset class is combined with unsustainable financing structure, conflicted governance, and retail distribution unsuited to the risk.
Corvid Partners approaches life settlement securitizations from the perspective of practitioners who have held these securities through the asset class's most consequential dislocation — inheriting a portfolio of life settlement bonds from Lehman Brothers at Barclays in September 2008, watching them trade into the single digits as technical selling overwhelmed actuarial reality, and participating in the recovery as mortality experience confirmed that the underlying policies were performing in line with their fundamental economics. That experience — combined with the multidisciplinary framework of actuarial modeling, STOLI legal analysis, structural finance mechanics, and secondary market trading behavior that the asset class requires — positions Corvid to provide comprehensive analysis across advisory, investment, restructuring, and dispute-related contexts that no single-discipline practitioner can fully replicate.
https://www.sifma.org/resources/research/us-asset-backed-securities-statistics/
Bibliography
NAIC — Life Settlements Model Act (MDL-697, state licensing, disclosure, consumer protections)
https://content.naic.org/sites/default/files/inline-files/MDL-697.pdf
NAIC — Consumer Guide to Life Settlements
https://content.naic.org/sites/default/files/consumer_life_settlements.pdf
SEC — Life Settlements Risk Alert
https://www.sec.gov/about/offices/ocie/riskalert-lifesettlements.pdf
SEC — Rule 144A Guidance (private placement framework for life settlement note issuances)
https://www.sec.gov/divisions/corpfin/guidance/securitiesactrules-interps.htm
SEC — GWG Administrative Proceeding
https://www.sec.gov/litigation/admin/2022/33-11031.pdf
DOJ — GWG Bankruptcy Announcement
https://www.justice.gov/usao-sdtx/pr/gwg-holdings-inc-files-bankruptcy
Investopedia — Life Settlement
https://www.investopedia.com/terms/l/life-settlement.asp
Investopedia — Death Bond
https://www.investopedia.com/terms/d/deathbond.asp
S&P Global Ratings — Life Settlement Securitization Methodology
Fitch Ratings — Life Settlement Securitization Criteria
Swiss Re Institute — Insurance-Linked Securities
NBER — Securitization of Life Settlements
https://www.nber.org/papers/w11352
SSRN — Life Settlement Valuation Research
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1106964
University of Pennsylvania Law School — Life Settlement Legal Issues
https://scholarship.law.upenn.edu/faculty_scholarship/143
Skadden — STOLI Litigation Overview (insurable interest at inception voiding cases, major jurisdictions)
Delaware Supreme Court — Insurable Interest Case Law
https://law.justia.com/cases/delaware/supreme-court/2011/174-2011.html
CAS Forum — Actuarial Issues in Life Settlements
https://www.casact.org/sites/default/files/database/forum_2009_01forum_09wforum_01.pdf
North American Actuarial Journal — Dating Death: An Empirical Comparison of Medical Underwriters (AVS, 21st Services, Fasano, LSI as four major U.S. medical underwriters; LEPr formed October 2010 by AVS/21st/EMSI/ISC; LISA/Fasano separate position on A/E reporting; AVS updated 2008 and 2012; 21st updated 2008 and 2014; pre-2006 estimates approximately 10% too short)
https://www.tandfonline.com/doi/full/10.1080/10920277.2019.1585881
PMC/NIH — Evaluating Life Expectancy Evaluations (Fasano Associates dataset 2001-2013 analysis; LE estimates before 2006 approximately 10% too short; modern estimates close to zero systematic error; IDLE metric defined)
https://pmc.ncbi.nlm.nih.gov/articles/PMC6583892/
Fasano Associates — Enhanced Services (physician-centric medical assessments; 18 Physician Medical Directors; 200,000 lives underwritten 2001-2023; Actual-to-Expected 101% independent confirmation; 20-year mortality data)
https://fasanoassociates.com/enhanced-services/
Global Insurance Settlements Funds — Mortality Estimates Life Settlements (Big Five defined: AVS, TwentyFirst, Fasano; competition improving accuracy; conservative 2020 updates creating buying opportunity)
https://www.gisfunds.com/mortality-estimates-life-settlements/
ELSA — European Life Settlement Association Factsheet (secondary market $12.2B peak 2007, $1.3B low 2011, recovery through 2020s; tertiary market development post-crisis)
https://elsa-sls.org/wp-content/uploads/2023/09/ELSA-Fact-Sheet-Q3.pdf
AIR Asset Management — Life Settlement Market Maturation (tertiary market now exceeds secondary volume; specialist managers proliferated post-GFC; institutional investor base stickier; less leverage post-crisis)
https://airassetmanagement.com/insights/life-settlement-market-ready-to-flex-its-newfound-maturity
Windsor Life Settlements — Volatile Stock Market Has Investors Eyeing Life Settlements ($45B+ annual face value projected 2027, up from $22B 2020 per ISC Services; Apollo and Blackstone named entrants; 8-12% target IRR per Conning & Co.)
https://windsorlifesettlements.com/why-investors-eyeing-life-settlements/
Wikipedia — Life Settlement ($4.6B face value 2020, 3,241 policies; 267M policies in force 2018; 10M lapses annually; historical market growth)
https://en.wikipedia.org/wiki/Life_settlement
ScienceDirect — Efficiency Effects of Life Settlement on the Life Insurance Market ($12.2B 2007 peak to $2.12B 2013 per Conning Research; 43.6% annual growth rate 2002-2007 per The Deal)
https://www.sciencedirect.com/science/article/abs/pii/S0927538X19300812
FAU — Performance and Risks of Open-End Life Settlement Funds (37.30% total return December 2003 to June 2010, third highest of all asset classes; only hedge funds and government bonds higher; low volatility; moderate drawdown during 2007-2009 crisis)
https://www.vwrm.rw.fau.de/files/2016/05/Life_settlement_funds_2011-02-11_WP.pdf
Investment Fraud Lawyers — GWG L Bonds (Brad Heppner arrested November 4 2025, United States v. Heppner Case 25 Cr. 503 SDNY, trial April 6 2026; $91.3M total settlements June 2025; $31.48 per $1,000 bonds = ~3 cents on dollar; life settlement portfolio sold October 2023 for $10M; bankruptcy judge "no material recovery")
KlaymanToskes — GWG Holdings L Bonds Lawsuit ($1.626B outstanding at bankruptcy, April 20 2022 Chapter 11 SDTX Case 22-90032; $3M net assets remaining April 2025 for 26,000 bondholders; bonds canceled August 1 2023; WDT Interests issued)
https://klaymantoskes.com/gwg-holdings-l-bonds-lawsuit/
Iorio Law — GWG L Bond Settlement Beneficient Heppner ($50.5M Beneficient settlement March 7 2025; $91.3M aggregate through June 2025; $59.8M estimated net to bondholders; 3.69% of $1.626B outstanding; $31.48 per $1,000 bond)
https://www.iorio.law/blog/gwg-l-bond-settlement-beneficient-heppner/
SSEK Law Firm — GWG Holdings L Bonds (Emerson Equity managing broker-dealer; Aegis Capital, Centaurus Financial, NI Advisors named selling firms; $25K minimum; 6% redemption penalty; auto-renewable feature; >50% of bonds not repaid at maturity but replaced)
https://www.investorlawyers.com/gwg-holdings-l-bonds.html
Octus — GWG Bondholder Lawsuit (27,000 bondholders class; $1.626B outstanding at filing; primary assets life settlement portfolio valued ~$800M and Beneficient equity; Beneficient IPO June 8 2023 $4B market cap; fire sale allegations; RICO claims)
https://octus.com/resources/articles/gwg-bondholder-lawsuit-secret-romance-fire-sale/
Journal of Structured Finance — Life Settlement Securitization Articles
Journal of Risk and Insurance — Insurance Risk Securitization
Harvard Business Law Review — Securitization and Regulation
Journal of Banking and Finance — Longevity Risk and Structured Products
Corvid Partners